1. Home
  2. BRTX vs PWM Comparison

BRTX vs PWM Comparison

Compare BRTX & PWM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BRTX
  • PWM
  • Stock Information
  • Founded
  • BRTX 1997
  • PWM 2018
  • Country
  • BRTX United States
  • PWM Hong Kong
  • Employees
  • BRTX N/A
  • PWM N/A
  • Industry
  • BRTX Managed Health Care
  • PWM
  • Sector
  • BRTX Health Care
  • PWM
  • Exchange
  • BRTX Nasdaq
  • PWM Nasdaq
  • Market Cap
  • BRTX 12.6M
  • PWM 12.4M
  • IPO Year
  • BRTX N/A
  • PWM 2023
  • Fundamental
  • Price
  • BRTX $1.67
  • PWM $0.35
  • Analyst Decision
  • BRTX Strong Buy
  • PWM
  • Analyst Count
  • BRTX 1
  • PWM 0
  • Target Price
  • BRTX $18.00
  • PWM N/A
  • AVG Volume (30 Days)
  • BRTX 256.1K
  • PWM 180.3K
  • Earning Date
  • BRTX 08-12-2025
  • PWM 07-07-2025
  • Dividend Yield
  • BRTX N/A
  • PWM N/A
  • EPS Growth
  • BRTX N/A
  • PWM N/A
  • EPS
  • BRTX N/A
  • PWM N/A
  • Revenue
  • BRTX $391,000.00
  • PWM $639,912.00
  • Revenue This Year
  • BRTX $391.52
  • PWM N/A
  • Revenue Next Year
  • BRTX $3.50
  • PWM N/A
  • P/E Ratio
  • BRTX N/A
  • PWM N/A
  • Revenue Growth
  • BRTX 161.54
  • PWM 83.60
  • 52 Week Low
  • BRTX $1.21
  • PWM $0.31
  • 52 Week High
  • BRTX $2.55
  • PWM $2.70
  • Technical
  • Relative Strength Index (RSI)
  • BRTX 46.78
  • PWM 42.41
  • Support Level
  • BRTX $1.57
  • PWM $0.33
  • Resistance Level
  • BRTX $1.72
  • PWM $0.37
  • Average True Range (ATR)
  • BRTX 0.13
  • PWM 0.03
  • MACD
  • BRTX -0.01
  • PWM -0.00
  • Stochastic Oscillator
  • BRTX 20.65
  • PWM 28.75

About BRTX BioRestorative Therapies Inc. (NV)

BioRestorative Therapies Inc is a biotechnology company based in the United States. It focuses on the development of regenerative medicine products and therapies using cell and tissue protocols, primarily involving adult (non-embryonic) stem cells. The company's two core development programs include the Disc/Spine Program, which involves cell therapy candidate, BRTX-100, a product formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow; and the Metabolic Program, which includes the development of cell-based therapy to target obesity and metabolic disorders using brown adipose-derived stem cells, to generate brown adipose tissue.

About PWM Prestige Wealth Inc.

Prestige Wealth Inc is engaged in providing private wealth management services and asset management to high-net-worth and ultra-high-net-worth individuals and enterprises through its subsidiaries.

Share on Social Networks: